George:
Glad you in with us!!!
I'll only attempt to answer your question number 1. IMO, if things work out at the Smith Barney confernce, and we get some institutional buying, I think we can get to 4 by the time AndroVir is sold in March. Both AndroVir and AndroCar have great potential according to the study results.
The one negative I see is hopefully paracelsian is getting the buyers lined up to purchase these compounds. Especially for AndroVir. As Robin and several others have stated, Paracelsian needs the revenue to obviously cover startup costs, and the cost for east-West Herbs. They may still need a stock sale to cover everthing.
Last year in March - June, the stock was really rolling. Since then, it has really slumped. We need some good news, and then we need something to sustain the stock price, especially if they are going to need another stock sale.
If all works out, 4 by March, 7 - 10 by December, 1997 (IMO).
Rick (hope I am right :-) |
